Metfoliquid Geriasan

Metformin, the active ingredient in Metfoliquid Geriasan, is a biguanide presented as an oral formulation for oral use. It is used to lower blood glucose in adults with type 2 diabetes mellitus. GNH USA supplies Metfoliquid Geriasan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin is indicated for conditions affecting glucose metabolism and insulin sensitivity.

Type 2 diabetes mellitus: improves glycaemic control and reduces long‑term complications. Prediabetes (impaired glucose tolerance): helps delay progression to type 2 diabetes. Polycystic ovary syndrome (off‑label): may improve insulin resistance and menstrual regularity.

Metformin is associated with a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, often transient. - Abdominal discomfort: cramping or bloating. - Metallic taste: transient alteration of taste perception. - Loss of appetite: reduced desire to eat. - Upper‑respiratory symptoms: mild cough or sore throat.

Serious or Rare Side Effects: - Lactic acidosis: rare but potentially fatal metabolic acidosis. - Severe skin reactions: such as Stevens‑Johnson syndrome. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Vitamin B12 deficiency: may develop with long‑term use. - Hypoglycaemia: uncommon when used alone, more likely with concomitant insulin or sulfonylureas. - Acute pancreatitis: rare inflammatory condition of the pancreas.

Metformin requires careful assessment before and during therapy to minimise risks. - Renal function assessment: avoid use if eGFR <30 mL/min/1.73 m². - Hepatic impairment: monitor liver enzymes and avoid in severe disease. - Lactic acidosis risk: discontinue before major surgery or radiographic contrast studies. - Vitamin B12 monitoring: check levels periodically during long‑term therapy. - Pregnancy and lactation: evaluate benefit‑risk ratio with the prescriber. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Metformin may interact with several medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Iodinated contrast agents: increase risk of lactic acidosis; suspend metformin before and after the procedure. - Cimetidine: can raise metformin plasma concentrations. - Alcohol: potentiates lactic acidosis risk. - Certain antiretrovirals (e.g., didanosine): may increase toxicity. - Diuretics (loop or thiazide): may impair renal function and raise metformin levels.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycaemia symptoms. - ACE inhibitors or ARBs: monitor renal function and potassium. - Warfarin: occasional changes in INR; monitor coagulation. - Corticosteroids: may affect glucose control, requiring dose adjustment.